Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 7/20 | 0.77 |
| ▸ | HPGD | P15428 | 4/20 | 0.75 |
| ▸ | GABRA1 | P14867 | 5/20 | 0.70 |
| ▸ | GABRA5 | P31644 | 5/20 | 0.70 |
| ▸ | GABRA2 | P47869 | 5/20 | 0.70 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.70 |
| ▸ | GABRA3 | P34903 | 3/20 | 0.70 |
| ▸ | BRD4 | O60885 | 2/20 | 0.70 |
| ▸ | LMNA | P02545 | 2/20 | 0.70 |
| ▸ | CNR1 | P21554 | 1/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.67 |
| ▸ | RECQL | P46063 | 1/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.66 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.54 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.54 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.54 |
| ▸ | HTR2A | P28223 | 1/20 | 0.54 |
| ▸ | GABRP | O00591 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Perchlorate SCHEMBL11084792 | 0.96 | OPRK1 (0.71) | OPRK1HPGDGABRA1GABRA5GABRA2 | |
| Acetic Acid SCHEMBL10404825 | 0.95 | OPRK1 (0.73) | OPRK1HPGDGABRA1GABRA5GABRA2 | |
| Propionic Acid SCHEMBL10404824 | 0.93 | OPRK1 (0.70) | OPRK1HPGDGABRA1GABRA5GABRA2 | |
| SCHEMBL11075404 | 0.91 | OPRK1 (0.74) | OPRK1HPGDGABRA1GABRA5GABRA2 | |
| SCHEMBL10738545 | 0.90 | OPRK1 (0.78) | OPRK1HPGDGABRA1GABRA5GABRA2 | |
| Valeric Acid SCHEMBL10404748 | 0.89 | OPRK1 (0.65) | OPRK1HPGDGABRA1GABRA5GABRA2 | |
| SCHEMBL7326170 | 0.89 | OPRK1 (0.77) | OPRK1HPGDGABRA1GABRA5GABRA2 | |
| SCHEMBL7321230 | 0.89 | OPRK1 (0.80) | OPRK1HPGDGABRA1GABRA5GABRA2 | |
| SCHEMBL11079877 | 0.89 | OPRK1 (0.77) | OPRK1HPGDGABRA1GABRA5GABRA2 | |
| SCHEMBL10732708 | 0.89 | OPRK1 (0.77) | OPRK1HPGDGABRA1GABRA5GABRA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240230633-A1 | ENZYME-CONJUGATED MAGNETIC BEADS SUSPENDED IN INTERNAL STANDARD BUFFER | DH TECHNOLOGIES DEV PTE LTD (SG) | 2024-07-11 | — | — | US | claimed |
| WO-2022248979-A1 | ENZYME-CONJUGATED MAGNETIC BEADS SUSPENDED IN INTERNAL STANDARD BUFFER | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2022-12-01 | — | — | WO | claimed |
| WO-2016040822-A1 | READY-TO-CONSTITUTE ANALYTICAL PLATFORMS FOR CHEMICAL ANALYSES AND QUANTIFICATION | PINPOINT TESTING, LLC (US) | 2016-03-17 | — | — | WO | claimed |
| JP-2007525670-A | — | — | 2007-09-06 | — | — | JP | claimed |
| EP-1718971-A2 | SYSTEM AND METHOD FOR REAL-TIME DIAGNOSIS, TREATMENT, AND THERAPEUTIC DRUG MONITORING | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2006-11-08 | — | — | EP | claimed |
| WO-2005098429-A2 | SYSTEM AND METHOD FOR REAL-TIME DIAGNOSIS, TREATMENT, AND THERAPEUTIC DRUG MONITORING | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2005-10-20 | — | — | WO | claimed |
| EP-1027609-A2 | METHOD FOR DETERMINATION OF DRUGS OF ABUSE IN BIOLOGICAL SAMPLES | Varian, Inc. (US) | 2000-08-16 | — | — | EP | claimed |
| WO-1999022244-A2 | METHOD FOR DETERMINATION OF DRUGS OF ABUSE IN BIOLOGICAL SAMPLES | VARIAN, INC. (US) | 1999-05-06 | — | — | WO | claimed |
| EP-0121375-B1 | PROCESSES FOR PREPARING 1-(HYDROXYMETHYL)TRIAZOLOBENZODIAZEPINES AND 1-(AMINOMETHYL)TRIAZOLOBENZODIAZEPINES | THE UPJOHN COMPANY (US) | 1987-06-24 | — | — | EP | claimed |
| US-4588721-A | Treatment of negative symptoms of schizophrenia | THE UPJOHN COMPANY (US) | 1986-05-13 | — | — | US | claimed |
| EP-0139460-A2 | Benzodiazepines and their therapeutic use | THE UPJOHN COMPANY (US) | 1985-05-02 | — | — | EP | claimed |
| US-4501698-A | REACTION WITH PARAFORMALDEHYDE, SULFONYL HALIDE, AMINO COMPOUND | THE UPJOHN COMPANY (US) | 1985-02-26 | — | — | US | claimed |
| US-4479959-A | 8-CHLORO-1-/ HYDROXYMETHYL/ -6-PHENYL-4H-S-TRIAZOLO/4,3-ALL1,4/ BENZODIAZEPINE | THE UPJOHN COMPANY (US) | 1984-10-30 | — | — | US | claimed |
| EP-0121375-A1 | Processes for preparing 1-(hydroxymethyl)triazolobenzodiazepines and 1-(aminomethyl)triazolobenzodiazepines | THE UPJOHN COMPANY (US) | 1984-10-10 | — | — | EP | claimed |
| US-4476134-A | TRANQUILIZERS; NEUROLEPTIC AGENTS | THE UPJOHN COMPANY (US) | 1984-10-09 | — | — | US | claimed |
| US-4427590-A | Triazolobenzodiazepine derivatives | CIBA-GEIGY CORPORATION (US) | 1984-01-24 | — | — | US | claimed |
| JP-5059058-A | — | — | None | — | — | JP | disclosed |
| EP-4419255-A1 | READY-TO-CONSTITUTE ANALYTICAL PLATFORMS FOR CHEMICAL ANALYSES AND QUANTIFICATION OF ANALYTES IN BIOLOGICAL SAMPLES | Pinpoint Testing, LLC (US) | 2024-08-28 | — | — | EP | disclosed |
| US-3941799-A | 6-Substituted-11b-phenyl-3, 11bH-oxazirino[2,3-d]-s-triazol[4,3-a][1,4]benzodiazepines | CIBA-GEIGY CORPORATION (US) | 1976-03-02 | — | — | US | disclosed |
| US-3870706-A | 6H-S-TRIAZOLO{8 4,3-a{9 {8 1,4{9 BENZODIAZEPIN-6-ONES | CIBA GEIGY CORP | 1975-03-11 | — | — | US | disclosed |